Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Fiverr International Ltd (FVRR) vs Stryker Corporation (SYK) Price & Performance

Fiverr International LtdTrade
Stryker CorporationTrade

Price performance (Past 24H)

Key statistics

Fiverr International Ltd vs Stryker Corporation — how do they compare? Fiverr International Ltd trades at $8.76 (market cap $310.61M), while Stryker Corporation trades at $278.6 (market cap $106.24B). The key difference: Stryker Corporation is far larger — about 342× Fiverr International Ltd's market cap, and Stryker Corporation pays a 1.27% dividend while Fiverr International Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Fiverr International Ltd for 62 Days and Stryker Corporation for 20 Days on average.

FVRRSYK
Market Cap
$310.61M$106.24B
Volume
381,4592,982,001
Sector
MediaHealth
52-Week High
$23.60$388.35
52-Week Low
$8.47$269.75
Typical Hold Time
62 Days20 Days
Enterprise Value
$63.00M$117.70B
Dividend Yield
—1.27%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Fiverr International Ltd

Fiverr International (FVRR) trades at $8.70, up 2.35% on the day, but remains in a bearish technical trend with resistance near $9.00. Recent Q2 2026 earnings missed estimates, with revenue declining 10% year-over-year to $97.8 million, as AI adoption pressures lower-value freelance demand. The company maintains strong gross margins of 82% and trades at discounted valuations, including a P/E of 10.67 and P/S of 0.76. Cash flow trends show operational strength but negative net cash flow in 2025 and 2026.

The outlook is cautious; while valuations are low and profitability is improving, AI disruption and recent earnings misses pose significant headwinds. Analyst consensus is a 'Hold' with a $10.50 price target, reflecting near-term challenges but potential recovery if growth stabilizes. Key risks include competitive threats from AI tools and execution risks in adapting the business model.

Stryker Corporation

Stryker (SYK) trades at $279.15, up 1.36% on the day, amid a mixed technical and fundamental backdrop. The stock shows bearish technical signals with key support at $268 and resistance at $284, while fundamentals remain solid with a 14.43% net income margin and strong analyst consensus of 71% buy ratings. Recent news highlights ongoing legal scrutiny over manufacturing issues, but the company maintains robust cash flow and earnings growth, with Q3 2026 results pending.

Outlook: SYK offers growth potential with a consensus price target of $368.11, supported by profitability and innovation, but faces near-term risks from legal investigations and technical weakness. Investors should weigh strong fundamentals against sentiment headwinds.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FVRR

No sentiment data available yet.

SYK
1% Buy99% Sell
Avg holding period · 20 Days

Top news

Latest headlines on both assets

About Fiverr International Ltd

Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Writing and Translation, and Video and Animation among others.

Read more on FVRR →

About Stryker Corporation

Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.

Read more on SYK →